Tissue Expanders Market Trends

Tissue Expanders Market size was valued at USD 7.15 Billion in 2023 and is poised to grow from USD 7.65 Billion in 2024 to USD 13.14 Billion by 2032, growing at a CAGR of 7% during the forecast period (2025-2032).

Allergan, Mentor Worldwide, Sientra, and GC Aesthetics are some of the major companies in the highly competitive tissue expanders market. These companies, offering a range of advanced tissue expanders, are well-established in the markets for reconstructive and cosmetic surgery. The competition is also increasing with new entrants that focus on innovative, environmentally friendly, and biocompatible products. Businesses also spend their money on increasing the range of products they offer and improving patient results to maintain an edge in the market.  'Medtronic (USA)', 'Allergan (USA)', 'Sientra (USA)', 'Johnson & Johnson (USA)', 'Mentor Worldwide LLC (USA)', 'Polytech Health & Aesthetics GmbH (Germany)', 'GC Aesthetics (Ireland)', 'Laboratoires Arion (France)', 'PMT Corporation (USA)', 'AirXpanders, Inc. (USA)', 'Nagor Limited (UK)', 'Koken Co., Ltd. (Japan)', 'Eurosilicone (France)', 'Hans Biomed Co., Ltd. (South Korea)', 'Groupe Sebbin (France)', 'Guangzhou Wanhe Plastic Materials Co., Ltd. (China)', 'Abbvie Inc. (US)', 'Guangzhou YU-K Plastic Surgery Co., Ltd. (China)', 'Ideal Implant Incorporated (USA)', 'Biodermis Corporation (USA)'

Increasing Interest in Cosmetic Procedures: More demand for tissue expander cosmetic surgery arises from the growing attention on aesthetics and the look of a person. More individuals are opting for cosmetic surgeries in the form of breast augmentation and face reconstruction, increasing the demand for tissue expanders. The industry is increasing with more people opting for cosmetic changes due to growing disposable income, especially in Asia-Pacific. 

North America dominated the tissue expanders market with the largest revenue share of 43.4% in 2023. The infrastructures of the country are well developed, and hospitals are well equipped medically with the latest technology, all of which contributes to quality reconstructive and cosmetic surgeries. According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2021 Global Survey, of the 288897 cosmetic procedures performed across the globe, 24.1% were performed in the US. The increasing rate of breast cancer has increased the demand in Canada for tissue expansion. The continued technological innovation and awareness that keep on growing are anticipated to make North America lead the market in the next few years.